http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019180706-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f6eea174661e065b8d973c8729f20a6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
| filingDate | 2019-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b72e69d86d55a0bcb7be994fd4357cca |
| publicationDate | 2019-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2019180706-A1 |
| titleOfInvention | Methods and compositions for treating epilepsy and associated disorders |
| abstract | The present invention provides cannabinoid combinations comprising, as the only cannabinoids, cannabidiol (CBD), cannabidivarin (CBDV), and optionally Δ9-tetrahydrocannabinol (Δ9-THC), or an enantiomer, diastereomer, or racemate thereof, wherein the CBD and CBDV are at a weight ratio of from about 10: 1 to about 20: 1, and the CBD and Δ9-THC, when present, are at a weight ratio of from about 20: 1 to about 30: 1; pharmaceutical and nutraceutical compositions comprising the cannabinoid combination; and methods for treating epilepsy or a disorder associated therewith, or for improving the efficacy of an anti-epileptic treatment, by administering said cannabinoid combinations. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022123236-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2601755-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114209673-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022006636-A1 |
| priorityDate | 2018-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 112.